Funds holding “NBIX”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
5 positions across 5 funds. Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust Healthcare | Neurocrine Biosciences Inc | 64125C109 | EC | 1.99% | $21.5M | Jun 30, 2026 | full (170 positions) |
| HQL abrdn Life Sciences Investors Healthcare | Neurocrine Biosciences Inc | 64125C109 | EC | 0.40% | $2.7M | Jun 30, 2026 | full (145 positions) |
| BME BlackRock Health Sciences Trust Healthcare | Neurocrine Biosciences Inc | 64125C109 | EC | 0.30% | $1.7M | Jun 30, 2026 | full (152 positions) |
| GRX Gabelli Healthcare & WellnessRx Trust Healthcare | NEUROCRINE BIOSCIENCES INC | 64125C109 | EC | 0.01% | $16.9K | Jun 30, 2026 | full (195 positions) |
| BRW Saba Capital Income & Opportunities Fund U.S. Equity | Neurocrine Biosciences Inc | 64125C109 | EC | -0.00% | $-12K | Jul 31, 2026 | full (1,143 positions) |
Matching position names
Neurocrine Biosciences Inc · 4NEUROCRINE BIOSCIENCES INC · 1
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.